Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/2003
03/27/2003US20030060440 Oligodeoxynucleotide and its use to induce an immune response
03/27/2003US20030060437 Antisense modulation of dual specific phosphatase 5 expression
03/27/2003US20030060436 Treatment of parkinson's disease with oligonucleotides
03/27/2003US20030060435 Method of cancer treatment by p53 protein control
03/27/2003US20030060434 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
03/27/2003US20030060433 Reducing the severity of cancer
03/27/2003US20030060416 Blk genes, gene products and uses thereof in apoptosis
03/27/2003US20030060415 Internal entry, such as through an atrium or ventricle, or can be by an external entry through the chest wall; cardiovascular therapeutics
03/27/2003US20030060406 Nucleotide sequence that encodes an amino acid sequence by culturing the host cell for expression of polypeptide; agonist or antagonist
03/27/2003US20030059944 Method for expression of small antiviral RNA molecules within a cell
03/27/2003US20030059943 Inhibition of gene expression in preferential cell; obtain cells, infect with viral particles, recover infected cells, express viral sequences, monitor adjustment in gene expression
03/27/2003US20030059941 Transduction of bone marrow stromal cells; obtain cells, incubate with retroviral vector coding preferential enzymatic polypeptides, recover transform cell and monitor cell activity; for use as treatment of parkinson's disease
03/27/2003US20030059938 Presenilin-deficient multipotent cell lines and screening methods for intramembrane-regulated proteolytic activities using these lines
03/27/2003US20030059923 Polynucleotide encoding a novel human potassium channel alpha-subunit, K+alphaM1, and variants thereof
03/27/2003US20030059922 Sphingosine1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
03/27/2003US20030059918 Regulation of human serine/threonine protein kinase
03/27/2003US20030059908 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer and cardiovascular disorders
03/27/2003US20030059877 Human cystine knot polypeptide
03/27/2003US20030059875 Nucleotide sequences coding polypeptide for use in the treatment prevention and diagnosis of inflammatory blood and cancer disorders
03/27/2003US20030059874 Polypeptide for use in the treatment of autoimmune, inflammatatory, arthritic, atherosclerotic, allergenic, dermatitis, urticaria, adult respiratory distress syndrome, asthma, rhinitis, eczema and infections
03/27/2003US20030059869 Novel G protein-coupled receptor, GAVE3
03/27/2003US20030059864 Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection
03/27/2003US20030059859 Vertebrate protein for use in human therapeutic and diagnostics
03/27/2003US20030059805 Nucleotide sequences coding polyeptide for use in the treatment of growth disorders in humans
03/27/2003US20030059796 Detecting genes associated with controlling angiogenesis; obtain and culture endothelial cells, isolate ribonucleic acids, amplified or reduced concentrations of preferenial ribonucleic acids indicate association with angiogenesis
03/27/2003US20030059794 Adenoviral library assay for E2F regulatory genes and methods and compositions for screening compounds
03/27/2003US20030059793 Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof
03/27/2003US20030059787 Detection of preferential nucleotide sequences coding telomerase; obtain sample containing nucleotide sequences, incubate with probe, detect hybridization product, presence of product indicates gene for telomerase
03/27/2003US20030059773 Immunomodulatory formulations and methods for use thereof
03/27/2003US20030059771 Compositions and methods related to the Rig tumor suppressor gene and protein
03/27/2003US20030059768 Novel polypeptides and nucleic acids encoding same
03/27/2003US20030059767 Zinc finger protein derivatives and methods therefor
03/27/2003US20030059464 Delivering p21(protein) to hair follicles of a mammal by applying topically to skin areas of a mammal having multiple hair follicels, an effective amount of a nucleotide sequence encoding the p21 protein
03/27/2003US20030059463 Medical device
03/27/2003US20030059455 A defective recombinant adenovirus including at least one DNA sequence coding for all or an active part of a superoxide; useful for treating and/or preventing Parkinson's disease, Alzheimer's disease, Huntington's disease etc.
03/27/2003US20030059420 Comprises catalytic or stoichiometric lipid removal, wherein proteins and/or polypeptides (lysosoymal acid lipase) target receptors in and/or on the cell which lead to uptake into the lysosome
03/27/2003US20030059417 Methods and compositions for diagnosing and treating disorders involving angiogenesis
03/27/2003US20030059415 Embryonic stem cells, clinical applications and methods for expanding in vitro
03/27/2003US20030059413 For production of recombinant transduced stem/progenitor cells
03/27/2003US20030059412 Fot treatment of disorders of bone cartilage or lung defect (such as osteoporosis and cycstic fibrosis) via transfection comprising herpes thymidine kinase gene
03/27/2003US20030059408 Embryonic stem cells, clinical applications and methods for expanding in vitro
03/27/2003CA2484050A1 Cultured stromal cells and uses thereof
03/27/2003CA2461176A1 Treatment of central nervous system disorders by use of pdgf or vegf
03/27/2003CA2461065A1 Transductin-1 and transductin-2 and applications to hereditary deafness
03/27/2003CA2461056A1 Hiv-gag codon-optimised dna vaccines
03/27/2003CA2460778A1 Methods for testing and producing (-) strand rna virus vectors with reduced particle formation ability
03/27/2003CA2456193A1 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies
03/26/2003WO2002026978A1 Novel proteins, genes encoding them and method of using the same
03/26/2003EP1295944A2 GDP dissociation stimulating protein, brain-specific nucleosome assembly protein, skeletal muscle specific ubiquitin-conjugating enzyme, cell proliferation protein, phosphatidylinositolkinase, nel related proteins
03/26/2003EP1295896A1 Method for identifying or isolating a molecule and molecules identified thereby
03/26/2003EP1295611A1 Oligonucleotide-transferring preparations
03/26/2003EP1294922A2 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents
03/26/2003EP1294918A2 Replication deficient adenoviral tnf vector
03/26/2003EP1294895A2 Calpain protease 12
03/26/2003EP1294894A2 Human protein kinase "13305" and uses therefor
03/26/2003EP1294893A2 Modification of hepatitis b core antigen
03/26/2003EP1294883A2 Human extracellular matrix (ecm)-related tumor marker
03/26/2003EP1294881A2 Control of metabolism with compositions of the human 2-oxoglutarate carrier
03/26/2003EP1294877A2 Cgi-69 compositions and methods of use
03/26/2003EP1294876A2 Eg-vegf nucleic acids and polypeptides and methods of use
03/26/2003EP1294874A2 Cd154 variants and uses thereof
03/26/2003EP1294872A1 Human trp-like calcium channel protein-2 (tlcc-2)
03/26/2003EP1294866A2 Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation
03/26/2003EP1294864A2 Mutated furin polypeptides having improved characteristics
03/26/2003EP1294857A2 Genetically modified t-cells, method for producing them and use thereof
03/26/2003EP1294771A2 IMMUNIZATION OF DAIRY CATTLE WITH CHIMERIC GAPC PROTEIN AGAINST i STREPTOCOCCUS /i INFECTION
03/26/2003EP1294770A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
03/26/2003EP1294765A2 Il-17 molecules and uses thereof
03/26/2003EP1294761A2 Method for activating peroxisome proliferator activated receptor-gamma
03/26/2003EP1294755A2 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
03/26/2003EP1294754A1 Interferon-alpha induced gene
03/26/2003EP1294752A2 Angiogenesis-modulating compositions and uses
03/26/2003EP1294737A1 Antisense modulation of c/ebp beta expression
03/26/2003EP1294407A2 Dual recombinant gene therapy compositions and methods of use
03/26/2003EP1294406A2 Modulation of chromosome function by chromatin remodeling agents
03/26/2003EP1294393A2 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment and diagnosis of athersclerosis
03/26/2003EP1294365A2 Cytotoxic agents comprising single-stranded and/or looped dna
03/26/2003EP0835261B1 Ion channel
03/26/2003EP0431135B1 Particle-mediated transformation of animal somatic cells
03/26/2003EP0431128B1 Vector coding for self-assembled, defective, non-self-propagating viral particles
03/26/2003CN1406278A Expression of recombinant mature lysostaphin
03/26/2003CN1406136A Novel antibody with specificity for colon cancer
03/26/2003CN1406125A Method for transdermal or intradermal delivery of molecules
03/26/2003CN1405312A Recombinant virus capable of specific killing tumor relating to EB virus and constructing method thereof
03/26/2003CA2423858A1 Novel proteins, genes encoding them and method of using the same
03/25/2003US6538174 Animal model for transplantation
03/25/2003US6538173 Identifying gene involved in enhanced wound healing, using a first and a second form of a polymorphic DNA microsatellite marker, which can distinguish a first and a second mouse strains
03/25/2003US6538121 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
03/25/2003US6537972 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
03/25/2003US6537966 Follistatin-3
03/25/2003US6537965 Novel parathyroid hormone (PTH) peptide derivatives. In particular, the invention relates to PTH PTH-2 receptor agonist or antagonist properties to the derivatives.
03/25/2003US6537814 Compositions and methods for altering the biodistribution of biological agents
03/25/2003US6537813 Concurrent flow mixing methods and apparatuses for the preparation of gene therapy vectors and compositions prepared thereby
03/25/2003US6537807 Cells designated CD7+CD34-Lin-; use in treatment of genetic and infectious diseases; identification of substances to promote growth, engraftment, and differentiation of stem cells
03/25/2003US6537806 Compositions and methods for treating diabetes
03/25/2003US6537805 Self-deleting vectors
03/25/2003US6537784 Self-regulated apoptosis of inflammatory cells by gene therapy
03/25/2003US6537776 Synthetic ligation reassembly in directed evolution
03/25/2003US6537775 Gene involved in cadasil, method of diagnosis and therapeutic application
03/25/2003US6537774 UPS (undecaprenyl diphosphate synthase
1 ... 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 ... 870